covid-19 Archives | Page 7 of 76

Early Treatment with Pegylated Interferon Lambda for Covid-19 (Website)

The New England Journal of Medicine (NEJM)

9 February 2023

Reis G, et.al.
Among predominantly vaccinated outpatients with Covid-19, the incidence of hospitalization or an emergency department visit was significantly lower among those who received a single dose of pegylated interferon lambda than among those who received placebo.

keywords: covid-19, interferon, treatment, vaccines

Early Estimates of Bivalent mRNA Booster Dose Vaccine Effectiveness in Preventing Symptomatic SARS-CoV-2 Infection Attributable to Omicron BA.5– and XBB/XBB.1.5–Related Sublineages Among Immunocompetent Adults — Increasing Community Access to Testing Program, United States, December 2022–January 2023 (Website, Regulatory)

CDC/MMWR

3 February 2023

Link-Gelles R, Ciesla AA, Roper LE, et al.

keywords: covid-19, mRNA, omicron, vaccines

COVID-19 Mortality and Progress Toward Vaccinating Older Adults — World Health Organization, Worldwide, 2020–2022 (Website, Regulatory)

CDC/MMWR

3 February 2023

Wong MK, Brooks DJ, Ikejezie J, et al.
COVID-19–associated mortality among persons aged ≥60 years exceeded 80% of total COVID-19 mortality in 2020 and 2021 across all income groups.

keywords: covid-19, older adults, vaccination

Know Your Treatment Options for COVID-19 (Website, Video, Regulatory)

FDA

.

keywords: covid-19, paxlovid, treatment

FAQs- NIH OSP Review of Requests to Lower the Minimum Required Biosafety Containment Level for Research Subject to the NIH Guidelines (Website, Regulatory)

NIH OSP

In the last 2 years, the NIH OSP has received multiple requests to lower containment from BL3 to BL2 for research with certain agents, including SARS-CoV-2.

keywords: containment, covid-19, IBC, NIH, risk assessment

Features, Evaluation, and Treatment of Coronavirus (COVID-19) (Website, Publication)

NIH: StatPearl Publishing

9 January 2023

Cascella M, Rajnik M, Aleem A, et al.
The authors say: “This review article aims to comprehensively describe the etiology, epidemiology, pathophysiology, clinical features, diagnostic methods, and the latest novel therapeutics in the management of COVID-19.”

keywords: covid-19, histology, novel treatment, pathophysiology, variants, variants of interest

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022 (Website, Publication, Regulatory)

CDC/MMWR

30 December 2022

Surie D, DeCuir J, Zhu Y, et al.

keywords: bivalent, covid-19, immunocompetant adults, older adults, vaccines

Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Emergency Department or Urgent Care Encounters and Hospitalizations Among Immunocompetent Adults — VISION Network, Nine States, September–November 2022 (Website, Publication, Regulatory)

CDC/MMWR

30 December 2022

Link-Gelles R, Ciesla AA, Fleming-Dutra KE, et al.

keywords: bivalent, covid-19, immunocompetant adults, vaccines

Important Updates on COVID-19 Therapeutics for Treatment and Prevention (Website, Regulatory)

CDC HAN

20 December 2022

The majority of Omicron sublineages circulating in the United States have reduced susceptibility to the monoclonal antibody, bebtelovimab and the monoclonal antibody combination, cilgavimab and tixagevimab (EvusheldTM). Antiviral therapeutics for the treatment of COVID-19, ritonavir-boosted nirmatrelvir (Paxlovid™), remdesivir (Veklury®), and molnupiravir (Lagevrio™), retain activity against currently circulating Omicron sublineages.

keywords: covid-19, monoclonal antibody, paxlovid

Council of State and Territorial Epidemiologists/CDC Surveillance Case Definition for Multisystem Inflammatory Syndrome in Children Associated with SARS-CoV-2 Infection — United States (Website, Publication, Regulatory)

CDC/MMWR

16 December 2022

Melgar M, Lee EH, Miller AD, et al.

keywords: children, Covid infection, covid-19, MIS-C, Multisystem Inflamatory Syndrom

Resources with keywords: covid-19